Prostate Cancer
Prostate-specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma.
December 29, 2023
A comparative study of spinal cord compression management in metastatic prostate cancer: Teaching versus non-teaching hospitals in the United States.
December 28, 2023
Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk Stratification.
December 28, 2023
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401.
December 28, 2023
Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial.
December 28, 2023
Comparison of Capture Rates of the National Cancer Database Across Race and Ethnicity.
December 28, 2023
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
December 28, 2023
Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer.
December 27, 2023
The Impact of Nutrient Supply on Prostate Cancer Risk Worldwide.
December 27, 2023
Outcomes in patients with high- and very high-risk localized prostate cancer treated with definitive IMRT and long-term hormone therapy.
December 27, 2023
Evaluation of Recurrent Disease after Radiation Therapy for Patients Considering Local Salvage Therapy: Past vs. Contemporary Management.
December 26, 2023
What are the Most Important Objectives of Patients Undergoing Radical Prostatectomy? A Narrative Review.
December 26, 2023
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.
December 26, 2023
Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer.
December 26, 2023